Symbol="MDGL"
AssetType="Common Stock"
Name="Madrigal Pharmaceuticals Inc"
Description="Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic and liver diseases. The company is headquartered in West Conshohocken, Pennsylvania."
CIK="1157601"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3758614000"
EBITDA="-313836000"
PERatio="None"
PEGRatio="0"
BookValue="8.21"
DividendPerShare="0"
DividendYield="0"
EPS="-17.3"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.708"
ReturnOnEquityTTM="-2.127"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-17.3"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="331.17"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="93.6"
EVToRevenue="-"
EVToEBITDA="-3.293"
Beta="-0.744"
num_52WeekHigh="322.67"
num_52WeekLow="57.21"
num_50DayMovingAverage="243.52"
num_200DayMovingAverage="217.66"
SharesOutstanding="18289200"
DividendDate="2016-07-25"
ExDividendDate="None"
symbol="MDGL"
open="204.46"
high="208.00"
low="202.59"
price="205.30"
volume="228211.00"
latest_trading_day="2023-07-31"
previous_close="205.51"
change="-0.21"
change_percent="-0.1022%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="48"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="52"
Volume_recent_avg="366993"
Change_recent_avg="-0.82"
Delta_recent_avg="12.45"
Variance_recent_avg="6.22"
Change_ratio_recent_avg="-0.4"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="52"
Aroon_momentum_negative="48"
image_negative_thumbnail_id_1="1099"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0132.jpeg"
image_negative_thumbnail_id_2="505"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0100.jpeg"
image_neutral_thumbnail_id_1="576"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="652"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0056.jpeg"
image_positive_thumbnail_id_2="663"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0045.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
